Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 15;39(1):18.
doi: 10.1186/s40880-019-0364-x.

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma

Dehuan Xie  1 , Wanqin Cheng  2 , Shaowen Lv  1 , Rui Zhong  3 , Lei Wang  4 , Jiang Hu  1 , Mingli Wang  1 , Shaomin Huang  1 , Yong Su  5 , Yunfei Xia  6
Affiliations

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma

Dehuan Xie et al. Cancer Commun (Lond). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Illustration of target delineation in plan-I and plan-II. Magnetic resonance imaging (MRI)-I acquired before plan-I radiotherapy with cross-sectional T2-weighted images, T1-weighted images, and contrast-enhanced T1-weighted (T1 + C) images shows the primary tumor, which locates on the left side of the upper wall and extends into the nasal cavity, left medial pterygoid plate, and navicular fossa. In plan-I radiotherapy, the gross target volume of primary tumor (GTVnx-I) was outlined (red line). Clinical target volume 1-I (CTV1-I) (green line) is delineated with a 1.0-cm margin surrounding GTVnx-I. Clinical target volume 2-I (CTV2-I) (blue line) is delineated with a 0.5-cm margin surrounding CTV1-I. MRI-II acquired after 22 fractions of irradiation shows that the tumor greatly regressed. In plan-II radiotherapy, the residual tumor is delineated as GTVnx-II (red line). The regressing areas of the intracavitary area, the left medial pterygoid plate, and the navicular fossa lesion are included not in GTVnx-II but in CTV1-II (green line), which maintains the same as CTV1-I. CTV2-II is not delineated. GTVnx-I was copied to the CT-II for comparison (purple line)
See this image and copyright information in PMC

References

    1. Gai X, Wei Y, Tao H, Zhu J, Li B. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma. Oncotarget. 2017;8(16):27529–27540. doi: 10.18632/oncotarget.16770. - DOI - PMC - PubMed
    1. Wang W, Yang H, Hu W, Shan G, Ding W, Yu C, et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(2):617–621. doi: 10.1016/j.ijrobp.2009.08.036. - DOI - PubMed
    1. Yang H, Hu W, Wang W, Chen P, Ding W, Luo W. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2013;85(1):e47–e54. doi: 10.1016/j.ijrobp.2012.09.033. - DOI - PubMed
    1. Radiation Therapy Oncology Group Protocol 02-25. https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?stud.... Accessed 27 Mar 2019.
    1. Wang L, Wu Z, Xie D, Zeng R, Cheng W, Hu J, et al. Reduction of target volume and the corresponding dose for the tumor regression field after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Cancer Res Treat. 2018 doi: 10.4143/crt.2018.250. - DOI - PMC - PubMed